Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis

被引:0
|
作者
Cascino, I
Papoff, G
DeMaria, R
Testi, R
Ruberti, G
机构
[1] CNR,INST CELL BIOL,DEPT IMMUNOBIOL,I-00137 ROME,ITALY
[2] UNIV ROMA TOR VERGATA,DEPT EXPTL MED & BIOCHEM SCI,I-00173 ROME,ITALY
来源
JOURNAL OF IMMUNOLOGY | 1996年 / 156卷 / 01期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fas/Apo-1 (CD95) is an apoptosis-signaling cell surface receptor belonging to the TNF receptor family. Tumor cells resistant to Fas-mediated apoptosis have been described, but to date, the mechanisms responsible for this resistance are not well understood. We found that a series of apoptosis-resistant clones from human HUT78 lymphoma cells express a splicing variant coding for a truncated Fas molecule that lacks the intracellular death-signaling domain. The mutation responsible for the FasExo8Del expression was identified as a deletion-insertion in the intron 7/exon 8 region of the Fas gene. Moreover this mutation affects the phenotype in a dominant negative fashion, i.e., even in the presence of the normal receptor.
引用
收藏
页码:13 / 17
页数:5
相关论文
共 50 条
  • [41] The CD95(APO-1/Fas)/CD95L system
    Krammer, PH
    TOXICOLOGY LETTERS, 1998, 103 : 131 - 137
  • [42] Apoptosis and tumorigenesis in human cholangiocarcinoma cells involvement of Fas/APO-1 (CD95) and calmodulin
    Pan, G
    Vickers, SM
    Pickens, A
    Phillips, JO
    Ying, WZ
    Thompson, JA
    Siegal, GP
    McDonald, JM
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (01): : 193 - 203
  • [43] The CD95(APO-1/Fas)-mediated death-signal and diseases
    Krammer, PH
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 316 - 316
  • [44] Control of neuronal branching by the death receptor CD95 (Fas/Apo-1)
    C Zuliani
    S Kleber
    S Klussmann
    T Wenger
    M Kenzelmann
    N Schreglmann
    A Martinez
    J A del Rio
    E Soriano
    P Vodrazka
    R Kuner
    H-J Groene
    I Herr
    P H Krammer
    A Martin-Villalba
    Cell Death & Differentiation, 2006, 13 : 31 - 40
  • [45] Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras
    Fenton, RG
    Hixon, JA
    Wright, PW
    Brooks, AD
    Sayers, TJ
    CANCER RESEARCH, 1998, 58 (15) : 3391 - 3400
  • [46] CD95 (APO-1/Fas)-associating signalling proteins
    Peter, ME
    Kischkel, FC
    Hellbardt, S
    Chinnaiyan, AM
    Krammer, PH
    Dixit, VM
    CELL DEATH AND DIFFERENTIATION, 1996, 3 (02): : 161 - 170
  • [47] Fas (CD95, Apo-1) Ligand Gene Transfer
    Salah-Eddine Lamhamedi-Cherradi
    Youhai Chen
    Journal of Clinical Immunology, 2001, 21 : 24 - 29
  • [48] FasL-Fas/APO-1(CD95)系统
    孙长凯
    鞠躬
    生理科学进展, 1997, (02) : 42 - 44
  • [49] Fas/APO-1 (CD95) expression in myelodysplastic syndromes
    Lepelley, P
    Grardel, N
    Erny, O
    Iaru, T
    Obein, V
    Cosson, A
    Fenaux, P
    LEUKEMIA & LYMPHOMA, 1998, 30 (3-4) : 307 - 312
  • [50] CD95 (APO-1/Fas) and Parkinson's disease
    Hartmann, A
    Hunot, S
    Hirsch, EC
    Hirsch, C
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 425 - 425